BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/24/2023 9:09:47 AM | Browse: 195 | Download: 507
 |
Received |
|
2022-11-02 17:42 |
|
Peer-Review Started |
|
2022-11-02 17:44 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-11-27 04:48 |
|
Revised |
|
2022-12-20 09:09 |
|
Second Decision |
|
2023-01-31 03:25 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-01-31 04:02 |
|
Articles in Press |
|
2023-01-31 04:02 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-01-24 13:33 |
|
Typeset the Manuscript |
|
2023-02-01 16:41 |
|
Publish the Manuscript Online |
|
2023-02-24 09:09 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Implications of metabolic dysfunction associated fatty liver disease in COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Raja Chakraborty, Deepak Sharma, Devesh U Kapoor, Akanksha Dwivedi, Rakhi Khabiya and Saikat Sen |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Saikat Sen, PhD, Professor, Faculty of Pharmaceutical Science, Assam down town University, Gandhinagar, Panikhaiti, Guwahati 781026, Assam, India. saikat.pharm@rediffmail.com |
| Key Words |
Metabolic associated fatty liver disorder; COVID-19; Metabolic dysfunction; Hepatic damage; Cytokine storm |
| Core Tip |
Metabolic associated fatty liver disorder (MAFLD) is associated with fat accumulation and inflammation in hepatocytes, thus compromising liver function and making people more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, cytokine storm in SARS-CoV-2 infected MAFLD patients is considered severe and requires urgent attention. In addition, direct hepatic injury caused by SARS-CoV-2, enhanced levels of inflammatory cytokines, declined hepatic mitochondrial activity, compromised immunity, and altered expression of host angiotensin-converting enzyme 2 receptor are considered as some underlying mechanisms. Thus, patients with MAFLD require special attention to protect themselves from the SARS-CoV-2 infection or severe illness caused by SARS-CoV-2. |
| Publish Date |
2023-02-24 09:09 |
| Citation |
Chakraborty R, Sharma D, Kapoor DU, Dwivedi A, Khabiya R, Sen S. Implications of metabolic dysfunction associated fatty liver disease in COVID-19. World J Clin Cases 2023; 11(6): 1275-1286 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i6/1275.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i6.1275 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
